Etoricoxib as a treatment of choice for patients with SLCO2A1 mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case report

We reported a 22-year-old Emirati male with autosomal recessive primary hypertrophic osteoarthropathy caused by a possibly pathogenic homozygous non-synonymous variant in the SLCO2A1 gene (NM_005630.3: c.289C>T, p. Arg97Cys) presenting with joint swelling, forehead furrowing, and significant club...

Descripción completa

Detalles Bibliográficos
Autores principales: Albawa'neh, Areej, Al Mansoori, Mariam Ghareeb, Diab, Sehriban, Al Jasmi, Fatma, Akawi, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793897/
https://www.ncbi.nlm.nih.gov/pubmed/36583020
http://dx.doi.org/10.3389/fgene.2022.1053999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793897/
https://www.ncbi.nlm.nih.gov/pubmed/36583020
http://dx.doi.org/10.3389/fgene.2022.1053999

Ejemplares similares